Potential therapeutic target for triple-negative breast cancer

被引：5
|
作者：
Gilbert, Judith A.
机构：
来源：
LANCET ONCOLOGY | 2012年 / 13卷 / 08期
关键词：
D O I：
10.1016/S1470-2045(12)70298-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E330 / E330
页数：1
相关论文
共 50 条
  • [1] Triple-negative breast cancer: investigating potential molecular therapeutic target
    Papa, Anselmo
    Caruso, Davide
    Tomao, Silverio
    Rossi, Luigi
    Zaccarelli, Eleonora
    Tomao, Federica
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (01) : 55 - 75
  • [2] CXCL16 as a potential therapeutic target of triple-negative breast cancer
    Cho, Sun Wook
    Jang, Mi Gyeong
    Sun, Hyun Jin
    Lee, Han Sai
    Song, Young Shin
    Kim, Seong Keun
    CANCER RESEARCH, 2022, 82 (04)
  • [3] LRP5: a Potential Therapeutic Target in Triple-negative Breast Cancer
    Maubant, S.
    Maire, V.
    Tesson, B.
    Gentien, D.
    Marty-Prouvose, B.
    Cruzalegui, F.
    Depil, S.
    Tucker, G. C.
    Roman-Roman, S.
    Dubois, T.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 161 - 162
  • [4] LRP5: a potential therapeutic target in triple-negative breast cancer
    Maubant, Sylvie
    Maire, Virginie
    Tesson, Bruno
    Gentien, David
    Marty-Prouvost, Berengere
    Cruzalegui, Francisco
    Depil, Stephane
    Tucker, Gordon C.
    Roman-Roman, Sergio
    Dubois, Thierry
    CANCER RESEARCH, 2013, 73 (08)
  • [5] NOTCH4 Is a Potential Therapeutic Target for Triple-negative Breast Cancer
    Nagamatsu, Iori
    Onishi, Hideya
    Matsushita, Shojiro
    Kubo, Makoto
    Kai, Masaya
    Imaizumi, Akira
    Nakano, Kenji
    Hattori, Masami
    Oda, Yoshinao
    Tanaka, Masao
    Katano, Mitsuo
    ANTICANCER RESEARCH, 2014, 34 (1A) : 69 - 80
  • [6] Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
    Corkery, B.
    Crown, J.
    Clynes, M.
    O'Donovan, N.
    ANNALS OF ONCOLOGY, 2009, 20 (05) : 862 - 867
  • [7] Fatty acid synthase inhibition as a potential therapeutic target in triple-negative breast cancer
    Giro, A.
    Blancafort, A.
    Oliveras, G.
    Perez-Bueno, F.
    Dorca, J.
    Vinas, G.
    Puig, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S180 - S180
  • [8] GPR30: A potential therapeutic target in Triple-negative Inflammatory Breast Cancer
    Bittman-Soto, Xavier S.
    Rivera-Lopez, Adrian J.
    Mendez-Santacruz, Laura A.
    Peterson-Peguero, Esther A.
    FASEB JOURNAL, 2022, 36
  • [9] TRPML1 as a potential therapeutic target for triple-negative breast cancer: a review
    Pan, Ying
    Zhao, Qiancheng
    He, Haitao
    Qi, Yubo
    Bai, Yujie
    Zhao, Jia
    Yang, Yiming
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [10] FoxM1 as a potential therapeutic target for triple-negative breast cancer.
    Yom, Cha Kyong
    Lee, Kyung-Min
    Han, Wonshik
    Kim, Sung-Won
    Moon, Hyeong-Gon
    Noh, Dong-Young
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345